EP4403579
SAMSETNING FYRIR AND-ALFA4BETA7-MÓTEFNI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.5.2012EP published:
10.12.2025EP application number:
24167554.5
EP translation filed:
30.1.2026Grant published:
11.2.2026EPO information:
European Patent Register
Max expiry date:
1.5.2032Expiry date:
1.5.2026
Title in English:
FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODYLanguage of the patent:
English
Timeline
Today
2.5.2012EP application
10.12.2025EP Publication
30.1.2026Translation submitted
11.2.2026Registration published
1.5.2026Expires
Owner
Name:
Millennium Pharmaceuticals, Inc.Address:
40 Landsdowne Street, Cambridge, MA 02139, US
Inventor
Name:
DILUZIO, WillowAddress:
Gloucester MA, 01930, US
Name:
NGUYEN, Phuong M.Address:
Cambridge, MA, 02141, US
Name:
VARGA, Csanad M.Address:
Newton, MA, 02459, US
Name:
PALANIAPPAN, VaithianathanAddress:
Andover, MA, 01810, US
Name:
BROWN, JasonAddress:
Burlington, MA, 01803, US
Name:
FOX, Irving H.Address:
Dedham, MA, 02026, US
Name:
SCHOLZ, CatherineAddress:
North Reading, MA, 01864, US
Name:
JENKINS, Erica HelenAddress:
Cottenham, Cambridgeshire, CB24 8RB, GB
Name:
ROSARIO, MariaAddress:
Mystic, CT, 06355, US
Agent
Name:
Budde Schou A/SAddress:
Dronningens Tværgade 30, DK
Priority
Number:
201161481522 PDate:
2.5.2011Country:
US
Number:
201161544054 PDate:
6.10.2011Country:
US
Classification
Categories:
A61K 39/395, A61K 47/12, A61K 47/14, A61K 47/18, A61K 47/26, A61K 9/00, A61P 1/00, A61P 1/04, A61P 1/16, A61P 1/18, A61P 3/10, A61P 29/00, A61P 31/18, A61P 37/06, A61P 43/00